StockClub

VIRX

VIRXViracta Therapeutics, Inc.$ --
Viracta Therapeutics, Inc.

Viracta Therapeutics, Inc.

VIRX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2024FY2024 Q3
Revenue
0M USD
YoY -
Operating Income
-10M USD
YoY +18.4%
Net Income
-11M USD
YoY +16.2%
EPS
-0.27$
YoY +18.2%

Revenue

$0
FY2022 Q4$0
$0
Q4
FY2023 Q1$0
$0
Q1
FY2023 Q2$0
$0
Q2
FY2023 Q3$0
$0
Q3
FY2023 Q4$738,000
$738,000
Q4
FY2024 Q1$0
$0
Q1
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
Actual
$0 (-)

Net Income

$-29.5M
FY2022 Q4$-49.2M
$-49.2M
Q4
FY2023 Q1$-12.2M
$-12.2M
Q1
FY2023 Q2$-24.7M
$-24.7M
Q2
FY2023 Q3$-37.3M
$-37.3M
Q3
FY2023 Q4$-51.1M
$-51.1M
Q4
FY2024 Q1$-9.1M
$-9.1M
Q1
FY2024 Q2$-19M
$-19M
Q2
FY2024 Q3$-29.5M
$-29.5M
Q3
Actual
+$7.8M (+20.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2018MISS
Actual:$237,000
Est:$434,800
FY2018MISS
$237,000
FY2019BEAT
Actual:$2.1M
Est:$412,500
FY2019BEAT
$2.1M
FY2020IN-LINE
Actual:$120,000
Est:$120,000
FY2020IN-LINE
$120,000
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023IN-LINE
Actual:$0
Est:$0
FY2023IN-LINE
$0

Analyst Estimates